Background. Complicated skin and skin structure infections (cSSSIs) are characterized by infections with grampositive or gram-negative aerobic or anaerobic bacteria, as well as by a polymicrobial etiology. These invading microorganisms are recognized by pattern-recognition receptors (PRRs) of the innate immune system. This study assessed whether genetic variation in genes encoding PRRs influences the susceptibility to cSSSIs.
Background. Complicated skin and skin structure infections (cSSSIs) are characterized by infections with grampositive or gram-negative aerobic or anaerobic bacteria, as well as by a polymicrobial etiology. These invading microorganisms are recognized by pattern-recognition receptors (PRRs) of the innate immune system. This study assessed whether genetic variation in genes encoding PRRs influences the susceptibility to cSSSIs.
Methods. A total of 318 patients with cSSSI and 328 healthy controls were genotyped for 9 nonsynonymous single-nucleotide polymorphisms (SNPs) in PRR genes coding for Toll-like receptors (TLRs) 1, 2, 4, and 6; NOD-like receptor 2; and the signaling adaptor molecule TIRAP. Associations between susceptibility to cSSSIs and a SNP were investigated by means of logistic regression models. In an additional cohort of 74 healthy individuals in whom the same SNPs were genotyped, peripheral blood mononuclear cells (PBMCs) were obtained and stimulated with Staphylococcus aureus. Interleukin 6 concentrations were determined in supernatants by enzyme-linked immunosorbent assay to determine the correlation between genotypes and levels of IL-6 secretion.
Results. In the genetic association analysis, polymorphisms in TLR1 (S248N and R80T), TLR2 (P631H), and TLR6 (P249S) were associated with an increased susceptibility to cSSSIs. No association with susceptibility to cSSSIs was observed for polymorphisms TLR2 (R753Q), TLR4 (D299G and T399I), NOD2 (P268S), and TIRAP (S180L). In the functional analysis, individuals bearing the TLR1 248N or 80T allele showed lower IL-6 secretion upon stimulation with S. aureus.
Conclusions. Polymorphisms in TLR1, TLR2, and TLR6 are associated with increased susceptibility to cSSSIs. For TLR1, impaired proinflammatory cytokine production due to the polymorphism is most likely the mechanism mediating this effect.
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Complicated skin and skin structure infections (cSSSIs) involve deeper soft tissue, require substantial surgical intervention, or occur in a immunocompromised host with a comorbid condition that may affect the response to treatment [1] . Common examples of cSSSIs are soft-tissue abscesses, diabetic foot infections, and surgical-site and trauma-induced wound infections [1, 2] . Gram-positive or gram-negative aerobic or anaerobic bacteria, alone or as part of a polymicrobial infection, are the causative agents of cSSSIs, with Staphylococcus aureus and β-hemolytic streptococci being most frequent. [1] [2] [3] . The infection location, the clinical situation, and the medical history of the patient are important characteristics that determine the type of pathogens involved [1, 2] . cSSSIs are associated with significant morbidity and mortality leading to prolonged and expensive hospitalizations, with a considerable impact on healthcare resources utilization [4] . cSSSIs often require surgical debridement of the infection in combination with antibiotic therapy [2] . However, the increasing ability of bacteria to resist antibiotic treatment, such as methicillin-resistant S. aureus and vancomycinresistant enterococci, complicates management of these infections [5] . In addition, differences in severity and occurrence of cSSSIs in patients are not solely explained by comorbidities or the virulence of a certain pathogen, as previously healthy young individuals can develop a severe infection caused by components of the commensal flora [6] . For these reasons, there is a need to identify host factors that predispose to development of cSSSIs, to define a predictive profile for persons at risk of developing these infections and potential individualized diagnosis and treatment.
One of the most significant discoveries to help understand the role of the host defense system against invading pathogens is the identification of germ-line-encoded pattern-recognition receptors (PRRs) able to recognize conserved structures of microbial species called pathogen-associated molecular patterns (PAMPs) [7] . Currently, 5 major PRR classes have been described: Toll-like receptors (TLRs), nucleotide-binding domain leucine-rich repeat containing receptors (NLRs), C-type lectins, RNA helicase RIG-I-like receptors, and cytoplasmic DNA receptor AIM2-like receptors [8, 9] . Of these PRR families, TLRs were the first to be discovered, and 10 TLRs have since been characterized in humans. TLRs recognize PAMPs by Nterminal leucine-rich repeats followed by a transmembrane region leading to the cytoplasmic Toll/interleukin 1R homology (TIR) domain, which interacts with several adaptor proteins, such as like myeloid differentiation primary response gene 88 (MyD88) and MyD88 adaptor-like/Toll-interleukin 1 receptor domain-containing adaptor protein (Mal/TIRAP), activating transcription factors, resulting in proinflammatory and antiinflammatory cytokine production and generation of an adaptive immune response [8] .
Several TLRs have been implicated as important in the host defense against cSSSI pathogens. Gram-positive bacteria such as S. aureus contain cell wall components that initiate immune responses through TLR2 [10] , most often by the formation of heterodimers with either TLR1 or TLR6 [11, 12] . In contrast, lipopolysaccharide derived from the gram-negative bacterium Escherichia coli is recognized by TLR4 [13] . Furthermore, peptidoglycans of both gram-positive and gram-negative bacteria (S. aureus and Escherichia coli) are recognized by NOD2, a member of the NLR family of cytoplasmic receptors [14] .
Genetic variants of TLRs [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] , NOD2 [26] [27] [28] , and the signaling adaptor TIRAP [29, 30] have previously been associated with susceptibility to infections. However, none of these studies have systematically investigated the role of these PRRs in the susceptibility to cSSSIs. In this study, we hypothesized that polymorphisms in genes encoding PRRs or their signaling adaptors may influence host susceptibility to cSSSIs. To test this hypothesis, we determined the prevalence of 7 nonsynonymous single-nucleotide polymorphisms (SNPs) in TLR genes, 1 in the NLR (NOD2) gene and 1 in the gene encoding the signaling adaptor TIRAP, in a cohort of 318 patients with cSSSI and 328 healthy controls. The genetic studies were supported by functional assays investigating the influence of the specific polymorphisms on the capacity to induce interleukin 6 (IL-6) cytokine responses after stimulation of human peripheral blood mononuclear cells (PBMCs).
MATERIALS AND METHODS

Subjects
From a total population of 813 patients with cSSSI included in a large randomized, multicenter clinical trial [6] , 389 patients gave informed consent to participate in this genetic substudy. Reasons for noninclusion in the genetic substudy were absence of an invitation to participate in the genetic substudy (the major reason) or refusal to participate. Of the 389 patients, 71 were excluded because they were not white (n = 2) or not of Eastern European ethnicity (n = 69), resulting in 318 white patients with cSSSI from 7 East European countries who were eligible to participate in this study.
Inclusion of patients in the trial was performed from September 2006 to June 2008, in compliance with Food and Drug Administration guidance, in which the term "uncomplicated and complicated skin and skin structure infections" was used [31] . The FDA issued a new guidance document in 2010, which used the term "acute bacterial skin and skin structure infections" [32] . We used the term "cSSSI" in this study because not only terminology but also criteria for satisfying the definition of these infections have changed.
Inclusion criteria and definition of cSSSIs (subtype/diagnosis: major abscess, diabetic foot infection, wound infection, or infected ischemic ulcer) are described in detail in the trial report [6] . A total of 89% of patients with cSSSI had communityacquired infections, and the remaining 11% had nosocomial infections. Seventy percent of the patients with cSSSI had polymicrobial infections. In 97% of the infections, at least 1 gram-positive microorganism was isolated. The prevalence of the predominant pathogens, mainly S. aureus, β-hemolytic Streptococcus group A-G, and Enterococcus faecalis, causing these infections in patients with cSSSI are displayed in Table 1 .
A total of 328 Eastern European, white, healthy controls recruited from the community, the majority of whom were males, were selected to geographically match the patients with cSSSI. In addition, 74 Dutch, white, healthy individuals were recruited from the community to correlate their genotype with IL-6 secretion upon stimulation of PBMCs. All subjects gave informed consent for genetic analysis.
Genotyping
DNA from patients with cSSSI was extracted from blood collected in PAXgene DNA tubes (Qiagen, Hildesheim, Germany) according to the PLUS XL manual kit (LGC Genomics, Berlin, Germany). DNA from healthy controls was isolated using the Gentra Pure Gene blood kit (Qiagen), according to the manufacturer's protocol. Nonsynonymous SNPs of the analyzed PRR genes were selected from the National Center for Biotechnology Information SNP database if they had previously described associations with human disease or known functional effects on gene expression or protein function. In total, 9 nonsynonymous missense SNPs in genes TLR1, TLR2, TLR4, TLR6, NOD2, and TIRAP were genotyped (Table 2) . Gene fragments were amplified by a commercially available TaqMan SNP genotyping assays according to manufacturer's protocol on a 7300 real-time polymerase chain reaction system (Applied Biosystems, Foster City, CA). Quality control was performed by the incorporation of positive and negative controls and duplication of random samples across different plates.
In Vitro PBMC Stimulation and Cytokine Detection Assays
Venous blood was obtained from 74 healthy controls. PBMCs were isolated and stimulated as described earlier [33] , with minor modifications. In brief, PBMCs were isolated by density gradient centrifugation using Ficoll-Paque PLUS (GE Healthcare, Uppsala, Sweden). Next, PBMCs were washed twice with phosphate-buffered saline ( pH = 7.4), and concentrations were adjusted to 5 2 to induce IL-6 production, after which the plates were centrifuged and supernatants were collected. All supernatants were stored at −20°C. IL-6 concentrations were measured in supernatants by a commercially available enzyme-linked immunosorbent assay kit according to manufacturer's instructions (Sanquin Reagents, Amsterdam, the Netherlands).
Statistical Analysis χ 2 analysis of deviation from Hardy-Weinberg equilibrium (HWE) was performed for all 9 SNPs separately in healthy 
Abbreviations: AA, amino acid; ID, identification number. a The first nucleotide (and corresponding AA) is the ancestral nucleotide and therefore is considered the wild-type allele.
controls, using a Web-based HWE calculator [34] . The association between susceptibility to cSSSIs and a SNP were investigated by means of univariate logistic regression models, using IBM SPSS 18 software (IBM, Armonk, NY). SNPs were evaluated using dominant model analysis (in which heterozygotic and homozygotic individuals for the allelic variant are combined and compared to wild-type individuals) and recessive model analysis (in which wild-type and heterozygotic individuals are combined and compared to homozygotic individuals for the allelic variant). No correction for multiple testing was performed. Pairwise linkage disequilibrium (LD), D′, and r 2 ,
were calculated using IBM SPSS 18 software. Multivariate logistic regression analyses were performed assuming a dominant model. Model reduction was done via forward and backward model selection methods, and in the most complex model all 9 genotyped SNPs were considered. P values of <.05 were considered to be statistically significant. Odds ratios (ORs) and 95% confidence intervals (CIs) were reported for these tests of association.
All statistical analyses and graphs of the IL-6 concentrations in the in vitro PBMC stimulation assays were performed and created, respectively, using GraphPad Prism 5.00 software (GraphPad Software, La Jolla, CA). Results were stratified by genotype, and differences in IL-6 secretion between genotypes were analyzed by Mann-Whitney U tests.
RESULTS
Univariate Logistic Regression of Single Polymorphisms in PRR and Signaling Adaptor TIRAP Genes in Patients With cSSSI and Healthy Controls
Polymorphisms in genes of TLR1, TLR2, TLR4, TLR6, NOD2 and TIRAP were genotyped in 318 patients with cSSSI and 328 healthy controls for the analyses of genetic association with susceptibility to cSSSIs. In the dominant model, genotyping revealed an association between susceptibility to cSSSIs and 3 TLR polymorphisms: TLR1 S248N (P = .03; OR, 1 (Table 3 ). Polymorphism TLR1 R80T was borderline insignificant (P = .06; OR, 1.41 [95% CI, .98-2.03]). In contrast to healthy controls, patients with cSSSI were more often heterozygous or homozygous for the allelic variant of these SNPs. No association with susceptibility to cSSSIs was observed in individuals carrying polymorphisms in TLR2 R753Q, TLR4 D299G and T399I, NOD2 P268S, and TIRAP S180L (Table 3 ). In addition, recessive model analysis confirmed the association between susceptibility to cSSSIs and TLR1 S248N (P = .01; OR, 1.54 [95% CI, 1.13-2.11]) and showed borderline insignificance for TLR6 P249S (P = .06; OR, 1.60 [95% CI, .98-2.61]), whereas TLR2 P631H, TLR1 R80T, TLR2 R753Q, TLR4 D299G and T399I, NOD2 P268S, and TIRAP S180L did not influence susceptibility to cSSSIs (data not shown).
All genotyped SNPs were in HWE for the healthy controls (data not shown). LD analyses indicated that polymorphisms TLR1 S248N and TLR1 R80T (P < .0001; r 2 = 0.27; D′ = 0.53), TLR1 S248N and TLR6 P249S (P < .0001; r 2 = 0.47; D′ = 0.59), and TLR1 R80T and TLR6 P249S (P < .0001; r 2 = 0.26; D′ = 0.48) were not independent from another, although the strength of their correlation was observed to be low. In contrast, LD analyses for TLR4 D299G and TLR4 T399I revealed that these SNPs were perfectly correlated (P < .0001; r 2 = 1.00; D′ = 1.00). Functional Effects of TLR1 S248N and R80T, TLR2 P631H, and TLR6 P249S Polymorphisms on Cytokine Production
Multivariate Logistic Regression of Polymorphisms in PRR and
Functional consequences of the TLR polymorphisms associated with susceptibility to cSSSIs were studied by stimulation of PBMCs obtained from an additional cohort of 74 healthy volunteers. PBMCs were stimulated with S. aureus, the pathogen most frequently causing cSSSIs, or with the following specific TLR ligands: Pam 3 Cys for TLR1 and TLR2 and FSL-1 for TLR6. IL-6 secretion was assessed in cell culture supernatants after 24 hours of stimulation and was stratified on the basis of the particular TLR genotype. Unstimulated PBMCs did not induce detectable IL-6 cytokine responses (data not shown). Homozygosity (TT; n = 41) for the TLR1 S248N polymorphism was associated with dramatically lower IL-6 cytokine responses, compared with wild-type (CC; n = 3) and heterozygous (CT; n = 29) genotypes after S. aureus and Pam 3 Cys stimulation (Figure 1A and 1E, respectively) . Also, heterozygosity (GC; n = 13) for the TLR1 R80T polymorphism resulted in significantly lower IL-6 cytokine responses, compared with the wild-type (GG; n = 58) genotype after S. aureus but not Pam 3 Cys stimulation ( Figure 1B and 1F, respectively) . This decreased IL-6 cytokine response after S. aureus stimulation was not observed in individuals homozygous for the variant allele (CC; n = 2), most likely because of its low prevalence.\ No significant differences in IL-6 response could be detected between the wild-type (CC; n = 71) and heterozygous (CA; n = 2) genotypes of the TLR2 P631H polymorphism ( Figure 1C and 1G), again most likely because of the low prevalence of the allelic variant among the study participants. No homozygotes (AA; n = 0) for TLR2 P631H were present among the 74 individuals. A decreasing trend in IL-6 response was observed in PBMCs stratified for the TLR6 P249S polymorphism (CC, n = 22; CT, n = 39; TT, n = 11) after S. aureus but not FSL-1 stimulation, although results were not statistically significant ( Figure 1D and 1H) .
DISCUSSION
This study demonstrates that polymorphisms in PRR genes TLR1, TLR2, and TLR6 are associated with an increased susceptibility to cSSSIs. In the univariate logistic regression analysis, 3 polymorphisms were found to be associated with an increased susceptibility to cSSSIs: TLR1 S248N, TLR2 P631H, and TLR6 P249S, with borderline insignificance for TLR1 TLR2 P631H, and TLR6 P249S better explains the susceptibility to cSSSIs than models including TLR1 polymorphism S248N. In addition, PBMCs of individuals carrying the TLR1 allele 248N or 80T produced significantly less IL-6 in response to the cSSSI pathogen S. aureus. No association was observed with susceptibility to cSSSIs for polymorphisms in TLR2 R753Q, TLR4 D299G and T399I, NOD2 P268S, and TIRAP S180L.
The patients included in this study had predominantly grampositive bacterial infections caused by Staphylococcus, Streptococcus, and Enterococcus species [6] . It is important to observe that TLR1, TLR2, and TLR6 are the main innate immune receptors for recognition of gram-positive bacteria. For instance TLR2, as a homodimer, or in heterodimeric combination with either TLR1 or TLR6, recognizes cell wall components of S. aureus [11, 12] .
All of these cSSSI-associated polymorphisms have been previously linked to infectious disease. The TLR1 polymorphism S248N has been demonstrated to result in increased susceptibility to gram-positive infection in sepsis [25] , candidemia [21] , and leprosy [22] . The other TLR1 polymorphism R80T is associated with pancolitis [35] , invasive aspergillosis after hematopoietic stem cell transplantation [18] , and candidemia [21] . Furthermore, the TLR2 polymorphism P631H is significantly overrepresented in patients with tuberculosis, compared with contact controls [36] , whereas the TLR6 polymorphism P249S is associated with malaria [37] and invasive aspergillosis [18] .
In addition to the genetic association between PRR polymorphisms and cSSSIs, we also studied the functional consequences of these polymorphisms. Presence of the TLR1 248N or 80T allele results in significantly lower levels of IL-6 secretion, and a similar trend was observed for the TLR6 249S allele. IL-6 blockade by tocilizumab has been recently related to staphylococcal infections [38] , illustrating the potential relevance of the effects of TLR1 SNPs on IL-6 production. No differences in IL-6 response were detected in groups stratified for the TLR2 polymorphism P631H, most likely because of the rare occurrence of heterozygotes and the absence of homozygotes for the allelic variant.
In a recent article by Ben-Ali et al, functional characterization of genetic variants in the TLR1-2-6 family were studied by transfection of various TLR constructs in HEK 293T cells containing a NF-κB luciferase reporter construct. Transfection of alleles TLR1 248N or 80T, TLR2 631H, and TLR6 249S all led to decreased NF-κB activation, compared with their ancestral variant, supporting our findings on the functional consequences of these polymorphisms. In addition, computational PolyPhen algorithm studies to predict the impact of nonsynonymous variants suggested that the TLR2 polymorphism P631H is a damaging mutation, whereas the TLR1 polymorphisms S248N and R80T, as well as the TLR6 polymorphism P249S, were classified as benign for protein function [39] .
This study showed that polymorphisms TLR1 S248N and TLR1 R80T, TLR1 S248N and TLR6 P249S, and TLR1 R80T and TLR6 P249S were in LD, although the strength of their correlation was observed to be low. In contrast, the TLR1 polymorphism S248N is in strong linkage with the nonsynonymous TLR1 polymorphism I602S (rs5743618; not studied). This polymorphism is associated with impaired trafficking of the receptor to the cell surface, leading to decreased cell membrane expression of TLR1 [25] . These findings may imply that the polymorphism I602S is causing the functional effects observed.
Presence of the TLR2 631H allele has been shown to decrease internalization of the TLR2 complex from the plasma membrane after recognition of its ligand [36] . Although internalization of the wild-type TLR2 complex is not necessary for intracellular signaling [40] , one can expect that inhibition of internalization by this polymorphism still could modulate functional responses as described by reduced NF-κB activation [39] .
Although the TLR2 R753Q, TLR4 D299G and T399I, NOD2 P268S, and TIRAP S180L polymorphisms were previously associated with infectious disease, no correlation between these polymorphisms and susceptibility to cSSSIs was observed here. The absence of an effect of these polymorphisms could in part be due to the type of pathogens present in patients with cSSSI, of which the majority are gram-positive bacteria.
To our knowledge, this is the first study investigating the role of SNPs in PRR genes in the susceptibility to cSSSIs. Unfortunately, a confirmation cohort was not available, and future studies should validate the findings reported here.
In conclusion, this study demonstrates that 4 polymorphisms in genes TLR1, TLR2, and TLR6 are associated with an increased susceptibility to cSSSIs. These infections are predominantly caused by gram-positive bacteria, in which these specific TLRs are of major importance for innate immune recognition. Functional characterization showed impaired TLR function and decreased cytokine responses. Although gram-positive bacterial infection and impaired TLR function strengthen the genetic associations observed, further studies are warranted to elucidate whether characterization of a predictive profile using TLR polymorphisms in TLR1, TLR2, and TLR6 can play a beneficial role for individuals at risk of developing cSSSIs.
Notes
